NORTH AMERICA AND EUROPE MINIMALLY INVASIVE PROSTATE CANCER SURGERY MARKET ANALYSIS

North America And Europe Minimally Invasive Prostate Cancer Surgery Market, By Product Type (Hand (Resectoscope, Linear Cutter, Insufflators, Curved Stapler, Endoscopic Trocars, Prostatic Retractor, Cryoablation Device, Others), Monitoring & Visualization (Cameras & Video Support, Endoscopic Trocars with Optical View), Powered (Electrosurgical Unit, Lasers)), By Application (Laparoscopy, Robotics, Brachytherapy, Cryosurgery), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) and by Region (North America, and Europe)

Published In : Aug 2023
Code : CMI4079
Pages :140
Formats :
Excel and PDF
Industry : Medical Devices

Regional Analysis

North America and Europe Minimally Invasive Prostate Cancer Surgery Market - Regional Analysis

Among regions, North America is estimated to hold a dominant position in the North America and Europe minimally invasive prostate cancer surgery market over the forecast period. North America holds 60% of the market share due to increasing research and developments, which is expected to drive the North America and Europe minimally invasive prostate cancer surgery market growth over the forecast period. For instance, on June 6, 2023, Advanced Surgical Retractor Systems, a medical device company, announced the first exploratory laparotomy with the new TITAN CSR. TITAN CSR is a lightweight titanium surgical retractor for emergency and trauma surgeries delivering the speed of traditional self-retaining retractors and equivalent exposure of table-mounted systems, without a post or table attachment.

Geographies covered: